Trademark Overview
On Wednesday, October 15, 2025, a trademark application was filed for COURELI with the United States Patent and Trademark Office. The USPTO has given the COURELI trademark a serial number of 79437682. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 27, 2025. This trademark is owned by Novo Nordisk A/S. The COURELI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.